{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T13:39:59Z","timestamp":1783949999273,"version":"3.55.0"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.jconrel.2020.10.036","type":"journal-article","created":{"date-parts":[[2020,10,20]],"date-time":"2020-10-20T01:10:16Z","timestamp":1603156216000},"page":"1077-1089","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["Targeted delivery of lopinavir to HIV reservoirs in the mesenteric lymphatic system by lipophilic ester prodrug approach"],"prefix":"10.1016","volume":"329","author":[{"given":"Chaolong","family":"Qin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YenJu","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanshan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Fromont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sijia","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong Bong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atheer","family":"Zgair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattia","family":"Berton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Bettonte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teerapong","family":"Monmaturapoj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Concepci\u00f3n","family":"Medrano-Padial","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allen Alonso Rodr\u00edguez","family":"Ugalde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daria","family":"Vetrugno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi Ying","family":"Ee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Sheriston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuntao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Stocks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter M.","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavel","family":"Gershkovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2020.10.036_bb0005","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1056\/NEJM199709113371101","article-title":"A controlled trial of two nucleoside analogues plus Indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less","volume":"337","author":"Hammer","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2020.10.036_bb0010","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1056\/NEJM199709113371102","article-title":"Treatment with Indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy","volume":"337","author":"Gulick","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2020.10.036_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1073\/pnas.96.26.15109","article-title":"HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression","volume":"96","author":"Davey","year":"1999","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jconrel.2020.10.036_bb0020","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1056\/NEJMoa062360","article-title":"CD4+ Count\u2013guided interruption of antiretroviral treatment","volume":"355","author":"SMART","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2020.10.036_bb0025","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1086\/427695","article-title":"A prospective, randomized trial of structured treatment interruption for patients with chronic HIV type 1 infection","volume":"40","author":"Cardiello","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jconrel.2020.10.036_bb0030","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.immuni.2012.08.010","article-title":"Redefining the viral reservoirs that prevent HIV-1 eradication","volume":"37","author":"Eisele","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.jconrel.2020.10.036_bb0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0033948","article-title":"Impact of multi-targeted antiretroviral treatment on gut T cell depletion and HIV reservoir seeding during acute HIV infection","volume":"7","author":"Ananworanich","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2020.10.036_bb0040","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S2055-6640(20)30688-9","article-title":"Virological and immunological characteristics of HIV-infected individuals at the earliest stage of infection","volume":"2","author":"Ananworanich","year":"2016","journal-title":"J. Virus Erad."},{"key":"10.1016\/j.jconrel.2020.10.036_bb0045","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1086\/318524","article-title":"Productive infection of T cells in lymphoid tissues during primary and early human immunodeficiency virus infection","volume":"183","author":"Schacker","year":"2001","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jconrel.2020.10.036_bb0050","doi-asserted-by":"crossref","first-page":"13193","DOI":"10.1073\/pnas.94.24.13193","article-title":"Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy","volume":"94","author":"Chun","year":"1997","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jconrel.2020.10.036_bb0055","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1126\/science.278.5341.1295","article-title":"Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy","volume":"278","author":"Finzi","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2020.10.036_bb0060","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nature16933","article-title":"Persistent HIV-1 replication maintains the tissue reservoir during therapy","volume":"530","author":"Lorenzo-redondo","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2020.10.036_bb0065","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1073\/pnas.1318249111","article-title":"Persistent HIV-1 replication is associated with lower antiretroviral drug concentrations in lymphatic tissues","volume":"111","author":"Fletcher","year":"2014","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jconrel.2020.10.036_bb0070","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/nm880","article-title":"Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting","volume":"9","author":"Siliciano","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2020.10.036_bb0075","series-title":"Neuro-Immuno-Gastroenterology","first-page":"237","article-title":"Targeting immunomodulatory agents to the gut-associated lymphoid tissue","author":"Zgair","year":"2016"},{"key":"10.1016\/j.jconrel.2020.10.036_bb0080","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1084\/jem.20040874","article-title":"CD4 + T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract","volume":"200","author":"Brenchley","year":"2004","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jconrel.2020.10.036_bb0085","doi-asserted-by":"crossref","first-page":"11708","DOI":"10.1128\/JVI.77.21.11708-11717.2003","article-title":"Severe CD4 + T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy","volume":"77","author":"Guadalupe","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.jconrel.2020.10.036_bb0090","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/COH.0000000000000118","article-title":"Impact of antiretroviral therapy (ART) timing on chronic immune activation\/inflammation and end-organ damage","volume":"10","author":"Rajasuriar","year":"2015","journal-title":"Curr. Opin. HIV AIDS"},{"key":"10.1016\/j.jconrel.2020.10.036_bb0095","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3390\/v11020105","article-title":"Persistent viral reservoirs in lymphoid tissues in suppressive antiretroviral therapy","volume":"11","author":"Siddiqui","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.jconrel.2020.10.036_bb0100","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1038\/nm.4411","article-title":"Defining total-body AIDS-virus burden with implications for curative strategies","volume":"23","author":"Estes","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2020.10.036_bb0105","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.virol.2011.11.024","article-title":"Lymph nodes harbor viral reservoirs that cause rebound of plasma viremia in SIV-infected macaques upon cessation of combined antiretroviral therapy","volume":"423","author":"Horiike","year":"2012","journal-title":"Virology"},{"key":"10.1016\/j.jconrel.2020.10.036_bb0110","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1073\/pnas.1406554111","article-title":"Anti-HIV drug particles may overcome lymphatic drug insufficiency and associated HIV persistence","volume":"111","author":"Freeling","year":"2014","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jconrel.2020.10.036_bb0115","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1097\/01.aids.0000470770.30932.55","article-title":"Long-acting three-drug combination anti-HIV nanoparticles enhance drug exposure in primate plasma and cells within lymph nodes and blood","volume":"29","author":"Freeling","year":"2015","journal-title":"AIDS"},{"key":"10.1016\/j.jconrel.2020.10.036_bb0120","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1089\/aid.2014.0210","article-title":"Anti-HIV drug-combination nanoparticles enhance as well as triple-drug combination levels in cells within lymph nodes and blood in Primates","volume":"31","author":"Freeling","year":"2015","journal-title":"AIDS Res. Hum. Retrovir."},{"key":"10.1016\/j.jconrel.2020.10.036_bb0125","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1016\/j.xphs.2018.03.005","article-title":"Long-acting profile of 4 drugs in 1 anti-HIV Nanosuspension in nonhuman Primates for 5 weeks after a single subcutaneous injection","volume":"107","author":"Mcconnachie","year":"2018","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2020.10.036_bb0130","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0378-5173(86)90027-X","article-title":"Estimating the maximal potential for intestinal lymphatic transport of lipophilic drug molecules","volume":"34","author":"Charman","year":"1986","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2020.10.036_bb0135","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.addr.2007.09.007","article-title":"Lipid-based delivery systems and intestinal lymphatic drug transport: a mechanistic update","volume":"60","author":"Trevaskis","year":"2008","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2020.10.036_bb0140","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.ejps.2005.07.011","article-title":"Uptake of lipophilic drugs by plasma derived isolated chylomicrons: linear correlation with intestinal lymphatic bioavailability","volume":"26","author":"Gershkovich","year":"2005","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2020.10.036_bb0145","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jconrel.2018.07.022","article-title":"Lipophilic activated ester prodrug approach for drug delivery to the intestinal lymphatic system","volume":"286","author":"Lee","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2020.10.036_bb0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-15026-z","article-title":"Oral administration of cannabis with lipids leads to high levels of cannabinoids in the intestinal lymphatic system and prominent immunomodulation","volume":"7","author":"Zgair","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2020.10.036_bb0155","series-title":"23rd International AIDS Conference","article-title":"Targeting tipranavir to mesenteric lymph nodes (MLNs) for improved treatment of HIV\/AIDS","author":"Chu","year":"2020"},{"key":"10.1016\/j.jconrel.2020.10.036_bb0160","series-title":"Update of First-and Second-Line Antiretroviral Regimens","author":"World Health Organization","year":"2019"},{"key":"10.1016\/j.jconrel.2020.10.036_bb0165","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.2174\/138161210791293042","article-title":"Prodrug design of phenolic drugs","volume":"16","author":"F\u00e9rriz","year":"2010","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.jconrel.2020.10.036_bb0170","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1023\/A:1016071311190","article-title":"Structure activity relationships for substrates and inhibitors of mammalian liver microsomal carboxylesterases","volume":"13","author":"Huang","year":"1996","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2020.10.036_bb0175","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/anie.197805221","article-title":"Simple method for the esterification of carboxylic acids","volume":"17","author":"Neises","year":"1978","journal-title":"Angew. Chem. Int. Ed. Eng."},{"key":"10.1016\/j.jconrel.2020.10.036_bb0180","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1211\/jpp.61.01.0005","article-title":"The role of molecular physicochemical properties and apolipoproteins in association of drugs with triglyceride-rich lipoproteins: in-silico prediction of uptake by chylomicrons","volume":"61","author":"Gershkovich","year":"2009","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.jconrel.2020.10.036_bb0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejpb.2015.01.001","article-title":"Rapid conversion of the ester prodrug abiraterone acetate results in intestinal supersaturation and enhanced absorption of abiraterone: in vitro, rat in situ and human in vivo studies","volume":"90","author":"Stappaerts","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2020.10.036_bb0190","first-page":"355","article-title":"A lipophilic prodrug of Danshensu: preparation, characterization, and in vitro and in vivo evaluation","volume":"15","author":"Xue-jiao","year":"2017","journal-title":"Chin. J. Nat. Med."},{"key":"10.1016\/j.jconrel.2020.10.036_bb0195","doi-asserted-by":"crossref","first-page":"16","DOI":"10.14227\/DT110204P16","article-title":"Dissolution media simulating fasted and fed states","volume":"11","author":"Marques","year":"2004","journal-title":"Dissol. Technol."},{"key":"10.1016\/j.jconrel.2020.10.036_bb0200","doi-asserted-by":"crossref","first-page":"394","DOI":"10.2174\/157016207781024018","article-title":"Rev-dependent indicator T cell line","volume":"5","author":"Wu","year":"2007","journal-title":"Curr. HIV Res."},{"key":"10.1016\/j.jconrel.2020.10.036_bb0205","doi-asserted-by":"crossref","first-page":"9537","DOI":"10.1073\/pnas.1916054117","article-title":"PSGL-1 restricts HIV-1 infectivity by blocking virus particle attachment to target cells","volume":"117","author":"Fu","year":"2020","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jconrel.2020.10.036_bb0210","first-page":"3448","article-title":"Dietary fats and pharmaceutical lipid excipients increase systemic exposure to orally administered cannabis and cannabis-based medicines","volume":"8","author":"Zgair","year":"2016","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.jconrel.2020.10.036_bb0215","doi-asserted-by":"crossref","DOI":"10.1002\/bmc.4934","article-title":"Development and validation of a cost-effective and sensitive bioanalytical HPLC-UV method for determination of lopinavir in rat and human plasma","volume":"34","author":"Qin","year":"2020","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.jconrel.2020.10.036_bb0220","first-page":"374","article-title":"Mesenteric lymph: the bridge to future management of critical illness","volume":"8","author":"Fanous","year":"2007","journal-title":"J. Panc."},{"key":"10.1016\/j.jconrel.2020.10.036_bb0225","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1515\/cclm.1986.24.1.19","article-title":"Catalytic enzyme activity concentration in thoracic duct, liver, and intestinal lymph of the dog, the rabbit, the rat and the mouse","volume":"24","author":"Lindena","year":"1986","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.jconrel.2020.10.036_bb0230","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1007\/s11095-014-1579-9","article-title":"Profiling the role of deacylation-reacylation in the lymphatic transport of a triglyceride-mimetic prodrug","volume":"32","author":"Han","year":"2015","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2020.10.036_bb0235","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1021\/acs.molpharmaceut.5b00785","article-title":"Lipophilic prodrugs of SN38: synthesis and in vitro characterization toward oral chemotherapy","volume":"13","author":"Bala","year":"2016","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2020.10.036_bb0240","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1093\/jac\/dkp140","article-title":"Pharmacokinetics and biodistribution of amphotericin B in rats following oral administration in a novel lipid-based formulation","volume":"65","author":"Gershkovich","year":"2009","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.jconrel.2020.10.036_bb0245","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1093\/jac\/dkh487","article-title":"The intracellular pharmacology of antiretroviral protease inhibitors","volume":"54","author":"Ford","year":"2004","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.jconrel.2020.10.036_bb0250","doi-asserted-by":"crossref","first-page":"4316","DOI":"10.1021\/jm070284z","article-title":"Design and synthesis of HIV-1 protease inhibitors incorporating Oxazolidinones as P2\/P2\u2032 ligands in Pseudosymmetric dipeptide Isosteres","volume":"50","author":"Reddy","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jconrel.2020.10.036_bb0255","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1177\/095632020601700404","article-title":"AZT and AZT-monophosphate prodrugs incorporating HIV-protease substrate fragment: synthesis and evaluation as specific drug delivery systems","volume":"17","author":"Liotard","year":"2006","journal-title":"Antivir. Chem. Chemother."},{"key":"10.1016\/j.jconrel.2020.10.036_bb0260","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1124\/dmd.109.026708","article-title":"Binding of Lopinavir to human 1-acid glycoprotein and serum albumin","volume":"37","author":"Gulati","year":"2009","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jconrel.2020.10.036_bb0265","doi-asserted-by":"crossref","first-page":"F1","DOI":"10.1097\/00002030-200101050-00002","article-title":"ABT-378\/ritonavir plus stavudine and lamivudine for the treatment of antiretroviral-naive adults with HIV-1 infection: 48-week results","volume":"15","author":"Murphy","year":"2001","journal-title":"AIDS."},{"key":"10.1016\/j.jconrel.2020.10.036_bb0270","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ejps.2007.05.109","article-title":"Effect of a high-fat meal on absorption and disposition of lipophilic compounds: the importance of degree of association with triglyceride-rich lipoproteins","volume":"32","author":"Gershkovich","year":"2007","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2020.10.036_bb0275","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1002\/jps.23597","article-title":"The impact of lymphatic transport on the systemic disposition of lipophilic drugs","volume":"102","author":"Hu","year":"2013","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2020.10.036_bb0280","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ejps.2016.08.057","article-title":"QbD based development of proliposome of lopinavir for improved oral bioavailability","volume":"108","author":"Patel","year":"2016","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2020.10.036_bb0285","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.3109\/10717544.2016.1141260","article-title":"Statistical modeling, optimization and characterization of solid self-nanoemulsifying drug delivery system of lopinavir using design of experiment","volume":"23","author":"Patel","year":"2016","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2020.10.036_bb0290","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s12272-013-0154-y","article-title":"Development and evaluation of glyceryl behenate based solid lipid nanoparticles (SLNs) using hot self-nanoemulsification (SNE) technique","volume":"37","author":"Negi","year":"2014","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.jconrel.2020.10.036_bb0295","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1080\/17425255.2019.1604685","article-title":"Pharmacokinetics and pharmacodynamics of cytochrome P450 inhibitors for HIV treatment","volume":"15","author":"Gong","year":"2019","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.jconrel.2020.10.036_bb0300","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/s13181-015-0465-0","article-title":"A review of the toxicity of HIV medications II: interactions with drugs and complementary and alternative medicine products","volume":"11","author":"Stolbach","year":"2015","journal-title":"J. Med. Toxicol."},{"key":"10.1016\/j.jconrel.2020.10.036_bb0305","first-page":"789","article-title":"The pharmacology and metabolism of testosterone undecanoate (TU), a new orally active androgen","volume":"4","author":"Coert","year":"1975","journal-title":"Acta Endocrinol."},{"key":"10.1016\/j.jconrel.2020.10.036_bb0310","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1111\/jphp.12217","article-title":"A hybrid design to optimize preparation of lopinavir loaded solid lipid nanoparticles and comparative pharmacokinetic evaluation with marketed lopinavir\/ritonavir coformulation","volume":"66","author":"Ravi","year":"2014","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.jconrel.2020.10.036_bb0315","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/jphp.12716","article-title":"Comparative pharmacokinetic evaluation of lopinavir and lopinavir-loaded solid lipid nanoparticles in hepatic impaired rat model","volume":"69","author":"Ravi","year":"2017","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.jconrel.2020.10.036_bb0320","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ejps.2012.10.022","article-title":"Development of solid lipid nanoparticles (SLNs) of lopinavir using hot self nano-emulsification (SNE) technique","volume":"48","author":"Negi","year":"2013","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2020.10.036_bb0325","doi-asserted-by":"crossref","first-page":"4266","DOI":"10.1016\/S0021-9258(19)39557-2","article-title":"ApoC-II activation of lipoprotein lipase","volume":"265","author":"Goldberg","year":"1990","journal-title":"J. Biol. Chem."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365920306143?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365920306143?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T16:15:15Z","timestamp":1759162515000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365920306143"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":65,"alternative-id":["S0168365920306143"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2020.10.036","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeted delivery of lopinavir to HIV reservoirs in the mesenteric lymphatic system by lipophilic ester prodrug approach","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2020.10.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}